Evidence map›Paper›PMID 39959770›Full record

ArticleWorld journal of clinical cases2025

Rethinking the diagnosis and treatment of renal anastomotic hemangioma after partial nephrectomy.

Yun-Peng Guo, Gaurab Pokhrel, Yu-Yang Wang, Quan Wen, Gai Hang, Bo Chen

Abstract read
In one paragraph

Article in World journal of clinical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yun-Peng GuoTongliao Clinical Medical College, Inner Mongolia Medical University, Tongliao 028000, Inner Mongolia Autonomous Region, China.
Gaurab PokhrelFirst Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450000, Henan Province, China.
Yu-Yang WangTongliao Clinical Medical College, Inner Mongolia Medical University, Tongliao 028000, Inner Mongolia Autonomous Region, China.
Quan WenDepartment of Urinary Surgery, Tongliao City Hospital, Tongliao 028000, Inner Mongolia Autonomous Region, China.
Gai HangDepartment of Urinary Surgery, Tongliao City Hospital, Tongliao 028000, Inner Mongolia Autonomous Region, China.
Bo ChenDepartment of Urinary Surgery, Tongliao City Hospital, Tongliao 028000, Inner Mongolia Autonomous Region, China. chenmuxin@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal anastomotic hemangioma (AH) is a rare, benign vascular tumor with unique histopathological features, a disease that is clinically rare, and existing clinical cases offer different treatment options. As reported in the text, this is a very unusual case of renal AH with AH secondary to residual renal tissue after renal clear cell carcinoma, describing a rare renal AH and a history of renal clear cell carcinoma, including ultrasound, computed tomography and magnetic resonance imaging. However, the available imaging data and the literature do not provide an effective basis for the diagnosis of the disease, raising the lack of understanding and misdiagnosis, where the patient eventually underwent nephrectomy, but the author is not the most appropriate surgical treatment. The postoperative pathological results of the patient are benign lesions, and it is undeniable that nephrectomy is suspected to be overtreated. By reading the literature, we provide different insights into the treatment of the patient, and we hope that this paper can provide some help for the future clinical diagnosis and treatment.

Indexed as

Anastomotic hemangiomaCase reportComputed tomographyRenalUltrasound

Identifiers

PMID39959770
PMCPMC11606360

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.